The 11.08x P/S should be read against the denominator's collapse rather than as a rich multiple on a growing franchise; on annualized 2026Q2 revenue the effective multiple is materially higher still, so any re-rating depends almost entirely on pipeline events, not operating delivery. The 7.06x price-to-book is more troubling than it first appears, since book equity has already inverted to -$10.0M, which means the multiple is anchoring on an asset base that accumulated losses have consumed. Compared to profitable peer ACAD at 8.81x earnings and 10% ROIC, ALEC screens as a pure event-driven holding with no fundamental floor from current operations.

The gross margin prints of 85.6%, -99.2%, and 100.0% across the window are not a margin trend but an accounting artifact of near-zero revenue colliding with variable cost recognition, which suggests gross margin is analytically useless here and operating margin is the only interpretable line. That operating margin improved to -7.3% in 2026Q2 despite $3.3M of revenue appears to reflect a quarter of depressed cost recognition rather than structural improvement, and warrants monitoring against the prior quarter's -$24M operating loss. The most honest read of earning power is the cumulative loss base: roughly -$308M of net losses over ten quarters against an asset base now at $202.9M, a burn intensity that no margin expansion in the reported data offsets.

The ROE trajectory is a compounding-decay signal rather than a leverage story: as the equity denominator eroded from $178.9M to -$10.0M, the ratio mechanically worsened, so the -111.6% print reflects capital destruction more than operating leverage. With asset turnover pinned near 0.01 and near-zero capex, there is essentially no productive asset base generating returns, which means any recovery in ROIC would have to come from revenue re-emerging on programs already funded, not from efficiency gains. Investors should note that the disappearance of recent ROIC data removes the one metric that would distinguish a pipeline-assets company still deploying capital effectively from one that is simply liquidating.

The leverage ratio deterioration is entirely denominator-driven, so it should not be read as evidence of aggressive financing behavior; absolute debt has stayed modest and no interest coverage figure is reported, which likely reflects debt service small enough relative to other claims that coverage is not a binding constraint. The real credit question is whether the $32.8M of debt carries covenants or maturity triggers tied to equity or minimum liquidity, since a negative equity position can convert a small, well-laddered facility into a refinancing risk faster than the debt quantum suggests. Deferred revenue falling 41% to $162.9M compounds the concern, because it implies the collaboration obligations that historically funded operations are drawing down without evidenced replacement.